CNBX Pharmaceuticals Inc. (CNBX)
Total Valuation
CNBX has a market cap or net worth of $1.20 million. The enterprise value is $2.69 million.
| Market Cap | 1.20M |
| Enterprise Value | 2.69M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
CNBX has 1.26 million shares outstanding. The number of shares has increased by 60.09% in one year.
| Shares Outstanding | 1.26M |
| Shares Change (YoY) | +60.09% |
| Shares Change (QoQ) | +56.05% |
| Owned by Insiders (%) | 14.59% |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | 27.75 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | 15.90 |
| Debt / FCF | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1,600.24% |
| Return on Capital (ROIC) | -1,757.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.99M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CNBX has paid $4.83 million in taxes.
| Income Tax | 4.83M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.60% in the last 52 weeks. The beta is 1.46, so CNBX's price volatility has been higher than the market average.
| Beta (1Y) | 1.46 |
| 52-Week Price Change | -99.60% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 1.82 |
| Average Volume (30 Days) | 738,362 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | 685,138 |
| Pretax Income | -4.14M |
| Net Income | -8.97M |
| EBITDA | 96,822 |
| EBIT | -82,869 |
| Earnings Per Share (EPS) | -$5.04 |
Balance Sheet
The company has $47,748 in cash and $1.54 million in debt, giving a net cash position of -$1.49 million or -$1.19 per share.
| Cash & Cash Equivalents | 47,748 |
| Total Debt | 1.54M |
| Net Cash | -1.49M |
| Net Cash Per Share | -$1.19 |
| Equity / Book Value | -2.01M |
| Book Value Per Share | -1.60 |
| Working Capital | -2.36M |
Cash Flow
In the last 12 months, operating cash flow was -$639,317 and capital expenditures -$1,143, giving a free cash flow of -$640,460.
| Operating Cash Flow | -639,317 |
| Capital Expenditures | -1,143 |
| Free Cash Flow | -640,460 |
| FCF Per Share | -$0.51 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNBX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -750.76% |
| FCF Yield | -53.59% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -60.09% |
| Shareholder Yield | -60.09% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 12, 2022. It was a reverse split with a ratio of 1:120.
| Last Split Date | May 12, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:120 |